Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities.
D019774:Blood Coagulation Factor Inhibitors / Q000276:immunology; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D017558:Elective Surgical Procedures / Q000009:adverse effects* / Q000379:methods; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006467:Hemophilia A / Q000150:complications* / Q000276:immunology / Q000601:surgery; D002836:Hemophilia B / Q000150:complications* / Q000276:immunology / Q000601:surgery; D006488:Hemostasis, Surgical / Q000379:methods; D006801:Humans; D019637:Orthopedic Procedures; D011994:Recombinant Proteins / Q000627:therapeutic use*
D019774:Blood Coagulation Factor Inhibitors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa